Journal article
ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment.
Authors
Douketis J
Journal
Annals of Internal Medicine, Vol. 154, No. 10, pp. jc5–j07
Publisher
American College of Physicians
Publication Date
January 1, 2011
DOI
10.7326/0003-4819-154-10-201105170-02006
ISSN
1056-8751